No Result

View All Result

No products in the cart.

Home Tag lymphoma

Tag: lymphoma

#VisualAbstract OAsIS: Ibrutinib, obinutuzumab, and venetoclax was well-tolerated and showed high response rates in both untreated and relapsed mantle cell lymphoma

byKathleen Lau

March 5, 2021

#VisualAbstract Fondazione Italiana Linfomi (FIL) Phase 3 trial: Lenalidomide maintenance after autologous haematopoietic stem-cell transplantation (HSCT) in mantle cell lymphoma improves progression-free survival (PFS)

byKathleen Lau

January 8, 2021

#VisualAbstract Progression-Free Survival (PFS) was significantly longer with intensive chemotherapy in patients with advanced stage double or triple hit lymphoma (DHL, THL)

byKathleen Lau

January 7, 2021

Severe subtype of acute lymphoblastic leukemia susceptible to FDA-approved kinase inhibitors

COVID-19 susceptibility may be increased in patients with hematological malignancies compared to solid organ tumours

byNeel Mistryand1 others

December 24, 2020

1. Patients with hematological malignancies were found to be at an increased risk of COVID-19 and were more likely to ...

#VisualAbstract PET Scan Adapted Approach in Primary Mediastinal Large B-Cell Lymphoma (PMBCL) using R-CHOP

byKathleen Lau

December 17, 2020

$#VisualAbstract CONTRALTO Phase II: Venetoclax-Rituximab With or Without Bendamustine VS Bendamustine-Rituximab in Relapsed/Refractory Follicular Lymphoma$

#VisualAbstract CONTRALTO Phase II: Venetoclax-Rituximab With or Without Bendamustine VS Bendamustine-Rituximab in Relapsed/Refractory Follicular Lymphoma

byKathleen Lau

December 11, 2020

#VisualAbstract B-Cell Targeted Therapies in CANOMAD Syndrome

byKathleen Lau

December 4, 2020

Testosterone replacement in male cancer survivors helps improve body composition

byAlex Chanand1 others

March 21, 2020

1. Young male cancer survivors with low-normal serum morning total testosterone benefited from testosterone treatment as a therapeutic option to ...

PET scans in early-stage Hodgkin’s lymphoma may help guide therapy [RAPID trial]

Novel β-chain-targeting approach for the treatment of lymphoma [PreClinical]

byCorinne Foleyand1 others

February 4, 2018

1. The β-chain constant region of the T cell receptor (TCR) was targeted to specifically eliminate a population of malignant ...

Chimeric antigen receptor T-cell therapy elicits treatment response in patients with refractory B-cell lymphoma

byShani Chibberand1 others

January 1, 2018

1. Patients with refractory diffuse large B-cell or follicular lymphoma demonstrated high rates of remission when treated with anti-CD19 directed ...

Page 4 of 5 Prev 1 … 3 4 5 Next

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result